Smith & Nephew SNATS Inc (SNN) - Net Assets
Based on the latest financial reports, Smith & Nephew SNATS Inc (SNN) has net assets worth $5.29 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($10.46 Billion) and total liabilities ($5.17 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Smith & Nephew SNATS Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.29 Billion |
| % of Total Assets | 50.58% |
| Annual Growth Rate | 7.69% |
| 5-Year Change | -5.01% |
| 10-Year Change | 33.63% |
| Growth Volatility | 19.75 |
Smith & Nephew SNATS Inc - Net Assets Trend (1985–2025)
This chart illustrates how Smith & Nephew SNATS Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see SNN market cap.
Annual Net Assets for Smith & Nephew SNATS Inc (1985–2025)
The table below shows the annual net assets of Smith & Nephew SNATS Inc from 1985 to 2025. Also explore how fast is Smith & Nephew SNATS Inc growing its equity to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $5.29 Billion | +0.46% |
| 2024-12-31 | $5.26 Billion | +0.92% |
| 2023-12-31 | $5.22 Billion | -0.80% |
| 2022-12-31 | $5.26 Billion | -5.55% |
| 2021-12-31 | $5.57 Billion | +5.47% |
| 2020-12-31 | $5.28 Billion | +2.68% |
| 2019-12-31 | $5.14 Billion | +5.48% |
| 2018-12-31 | $4.87 Billion | +4.95% |
| 2017-12-31 | $4.64 Billion | +17.33% |
| 2016-12-31 | $3.96 Billion | -0.20% |
| 2015-12-31 | $3.97 Billion | -1.83% |
| 2014-12-31 | $4.04 Billion | -0.17% |
| 2013-12-31 | $4.05 Billion | +4.20% |
| 2012-12-31 | $3.88 Billion | +21.87% |
| 2011-12-31 | $3.19 Billion | +14.93% |
| 2010-12-31 | $2.77 Billion | +27.26% |
| 2009-12-31 | $2.18 Billion | +28.25% |
| 2008-12-31 | $1.70 Billion | -6.44% |
| 2007-12-31 | $1.82 Billion | -16.47% |
| 2006-12-31 | $2.17 Billion | +51.50% |
| 2005-12-31 | $1.44 Billion | +6.57% |
| 2004-12-31 | $1.35 Billion | +17.67% |
| 2003-12-31 | $1.14 Billion | +37.33% |
| 2002-12-31 | $833.21 Million | +41.42% |
| 2001-12-31 | $589.18 Million | +47.35% |
| 2000-12-31 | $399.84 Million | -55.20% |
| 1999-12-31 | $892.49 Million | +10.75% |
| 1998-12-31 | $805.88 Million | +5.68% |
| 1997-12-31 | $762.58 Million | +2.27% |
| 1996-12-31 | $745.62 Million | +19.23% |
| 1995-12-31 | $625.35 Million | -10.30% |
| 1994-12-31 | $697.12 Million | +35.58% |
| 1993-12-31 | $514.17 Million | -6.40% |
| 1992-12-31 | $549.35 Million | +1.97% |
| 1991-12-31 | $538.71 Million | +3.40% |
| 1990-12-31 | $521.01 Million | +29.67% |
| 1989-12-31 | $401.80 Million | -7.36% |
| 1988-12-31 | $433.72 Million | -2.82% |
| 1987-12-31 | $446.29 Million | +43.34% |
| 1986-12-31 | $311.35 Million | +13.80% |
| 1985-12-31 | $273.58 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Smith & Nephew SNATS Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4559.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $5.32 Billion | 100.64% |
| Common Stock | $175.00 Million | 3.31% |
| Other Comprehensive Income | $20.00 Million | 0.38% |
| Total Equity | $5.29 Billion | 100.00% |
Smith & Nephew SNATS Inc Competitors by Market Cap
The table below lists competitors of Smith & Nephew SNATS Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zydus Lifesciences Limited
NSE:ZYDUSLIFE
|
$11.96 Billion |
|
PRADA S.P.A.UNS.ADR/2 EO1
F:PRP0
|
$11.97 Billion |
|
One 97 Communications Limited
NSE:PAYTM
|
$11.98 Billion |
|
Samsung Heavy Industries
KO:010140
|
$11.98 Billion |
|
Manhattan Associates Inc
NASDAQ:MANH
|
$11.95 Billion |
|
KERRY GRP PLC ADR/1EO-12
F:KRZA
|
$11.95 Billion |
|
YTL Power International Bhd
KLSE:6742
|
$11.95 Billion |
|
CoStar Group Inc
NASDAQ:CSGP
|
$11.95 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Smith & Nephew SNATS Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,265,000,000 to 5,289,000,000, a change of 24,000,000 (0.5%).
- Net income of 626,460,544 contributed positively to equity growth.
- Dividend payments of 330,771,167 reduced retained earnings.
- Share repurchases of 503,173,109 reduced equity.
- New share issuances of 12,000,000 increased equity.
- Other comprehensive income increased equity by 497,000,000.
- Other factors decreased equity by 277,516,268.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $626.46 Million | +11.84% |
| Dividends Paid | $330.77 Million | -6.25% |
| Share Repurchases | $503.17 Million | -9.51% |
| Share Issuances | $12.00 Million | +0.23% |
| Other Comprehensive Income | $497.00 Million | +9.4% |
| Other Changes | $-277.52 Million | -5.25% |
| Total Change | $- | 0.46% |
Book Value vs Market Value Analysis
This analysis compares Smith & Nephew SNATS Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.31x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 44.87x to 2.31x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $0.62 | $28.01 | x |
| 1986-12-31 | $0.71 | $28.01 | x |
| 1987-12-31 | $1.02 | $28.01 | x |
| 1988-12-31 | $0.99 | $28.01 | x |
| 1989-12-31 | $0.62 | $28.01 | x |
| 1990-12-31 | $0.84 | $28.01 | x |
| 1991-12-31 | $0.89 | $28.01 | x |
| 1992-12-31 | $0.98 | $28.01 | x |
| 1993-12-31 | $1.17 | $28.01 | x |
| 1994-12-31 | $1.57 | $28.01 | x |
| 1995-12-31 | $1.39 | $28.01 | x |
| 1996-12-31 | $1.65 | $28.01 | x |
| 1997-12-31 | $1.67 | $28.01 | x |
| 1998-12-31 | $1.77 | $28.01 | x |
| 1999-12-31 | $2.04 | $28.01 | x |
| 2000-12-31 | $0.91 | $28.01 | x |
| 2001-12-31 | $1.27 | $28.01 | x |
| 2002-12-31 | $1.75 | $28.01 | x |
| 2003-12-31 | $2.45 | $28.01 | x |
| 2004-12-31 | $2.86 | $28.01 | x |
| 2005-12-31 | $3.04 | $28.01 | x |
| 2006-12-31 | $4.61 | $28.01 | x |
| 2007-12-31 | $3.91 | $28.01 | x |
| 2008-12-31 | $3.82 | $28.01 | x |
| 2009-12-31 | $4.92 | $28.01 | x |
| 2010-12-31 | $6.24 | $28.01 | x |
| 2011-12-31 | $7.12 | $28.01 | x |
| 2012-12-31 | $8.62 | $28.01 | x |
| 2013-12-31 | $8.93 | $28.01 | x |
| 2014-12-31 | $8.98 | $28.01 | x |
| 2015-12-31 | $9.09 | $28.01 | x |
| 2016-12-31 | $8.87 | $28.01 | x |
| 2017-12-31 | $10.61 | $28.01 | x |
| 2018-12-31 | $11.14 | $28.01 | x |
| 2019-12-31 | $11.75 | $28.01 | x |
| 2020-12-31 | $12.06 | $28.01 | x |
| 2021-12-31 | $12.69 | $28.01 | x |
| 2022-12-31 | $12.02 | $28.01 | x |
| 2023-12-31 | $23.88 | $28.01 | x |
| 2024-12-31 | $12.01 | $28.01 | x |
| 2025-12-31 | $12.12 | $28.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Smith & Nephew SNATS Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.84%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 10.14%
- • Asset Turnover: 0.59x
- • Equity Multiplier: 1.98x
- Recent ROE (11.84%) is below the historical average (22.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 25.05% | 11.23% | 0.95x | 2.36x | $41.12 Million |
| 1986 | 28.72% | 12.58% | 0.80x | 2.86x | $58.20 Million |
| 1987 | 31.53% | 13.73% | 0.83x | 2.75x | $95.95 Million |
| 1988 | 33.53% | 13.48% | 0.85x | 2.94x | $101.92 Million |
| 1989 | 54.09% | 12.96% | 0.84x | 4.96x | $120.33 Million |
| 1990 | 39.09% | 10.17% | 0.92x | 4.19x | $106.52 Million |
| 1991 | 19.22% | 5.04% | 0.94x | 4.07x | $35.81 Million |
| 1992 | 36.47% | 11.99% | 0.97x | 3.14x | $113.16 Million |
| 1993 | 31.30% | 11.46% | 1.07x | 2.54x | $109.42 Million |
| 1994 | -12.10% | -5.59% | 1.14x | 1.90x | $-153.93 Million |
| 1995 | 27.89% | 10.99% | 1.25x | 2.04x | $111.81 Million |
| 1996 | 27.74% | 11.29% | 1.27x | 1.93x | $132.19 Million |
| 1997 | 24.66% | 10.85% | 1.21x | 1.87x | $111.75 Million |
| 1998 | 19.31% | 8.90% | 1.16x | 1.87x | $74.99 Million |
| 1999 | 19.01% | 9.36% | 1.14x | 1.78x | $80.34 Million |
| 2000 | 77.51% | 18.29% | 1.18x | 3.60x | $269.94 Million |
| 2001 | 32.03% | 11.98% | 0.99x | 2.71x | $129.81 Million |
| 2002 | 22.17% | 10.33% | 0.90x | 2.39x | $101.43 Million |
| 2003 | 23.11% | 12.56% | 0.95x | 1.94x | $150.04 Million |
| 2004 | 21.54% | 12.11% | 0.82x | 2.17x | $155.36 Million |
| 2005 | 23.21% | 13.05% | 0.86x | 2.07x | $189.50 Million |
| 2006 | 34.27% | 26.81% | 0.86x | 1.49x | $527.60 Million |
| 2007 | 17.40% | 9.38% | 0.76x | 2.46x | $134.40 Million |
| 2008 | 22.19% | 9.92% | 0.84x | 2.65x | $207.10 Million |
| 2009 | 21.66% | 12.51% | 0.83x | 2.09x | $254.10 Million |
| 2010 | 22.18% | 15.52% | 0.84x | 1.71x | $337.70 Million |
| 2011 | 18.26% | 13.63% | 0.90x | 1.49x | $263.30 Million |
| 2012 | 18.77% | 17.62% | 0.73x | 1.45x | $340.60 Million |
| 2013 | 13.74% | 12.78% | 0.75x | 1.44x | $151.30 Million |
| 2014 | 12.40% | 10.85% | 0.63x | 1.81x | $97.00 Million |
| 2015 | 10.34% | 8.85% | 0.65x | 1.81x | $13.40 Million |
| 2016 | 19.81% | 16.79% | 0.64x | 1.86x | $388.20 Million |
| 2017 | 16.52% | 16.10% | 0.61x | 1.69x | $302.60 Million |
| 2018 | 13.60% | 13.52% | 0.61x | 1.65x | $175.60 Million |
| 2019 | 11.67% | 11.68% | 0.55x | 1.81x | $85.90 Million |
| 2020 | 8.49% | 9.82% | 0.41x | 2.09x | $-79.90 Million |
| 2021 | 9.41% | 10.05% | 0.48x | 1.96x | $-32.80 Million |
| 2022 | 4.24% | 4.28% | 0.52x | 1.90x | $-302.90 Million |
| 2023 | 5.04% | 4.74% | 0.56x | 1.91x | $-258.70 Million |
| 2024 | 7.83% | 7.09% | 0.56x | 1.97x | $-114.50 Million |
| 2025 | 11.84% | 10.14% | 0.59x | 1.98x | $97.56 Million |
Industry Comparison
This section compares Smith & Nephew SNATS Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,687,439,673
- Average return on equity (ROE) among peers: -86.13%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Smith & Nephew SNATS Inc (SNN) | $5.29 Billion | 25.05% | 0.98x | $11.96 Billion |
| Abbott Laboratories (ABT) | $26.81 Billion | 22.24% | 1.51x | $177.42 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-95.88 Million | 0.00% | 0.00x | $10.26 Million |
| Aethlon Medical Inc (AEMD) | $1.50 Million | -324.29% | 0.70x | $1.05 Million |
| Acutus Medical Inc (AFIB) | $-225.81 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $280.85 Million | -57.55% | 5.46x | $788.17 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $784.36K | -284.06% | 0.72x | $4.92 Million |
| Allurion Technologies, Inc. (ALUR) | $-77.98 Million | 0.00% | 0.00x | $1.25 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $7.63 Million | -202.23% | 0.23x | $4.09 Million |
| Artivion Inc (AORT) | $148.69 Million | 4.92% | 0.18x | $1.16 Billion |
| Apyx Medical Inc (APYX) | $21.33 Million | -20.34% | 0.56x | $124.69 Million |
About Smith & Nephew SNATS Inc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more